Dyslipidemia in adolescents and young adults with type 1 and type 2 diabetes: a retrospective analysis

International Journal of Pediatric Endocrinology
Grace KimSarah Lyons

Abstract

Youth onset type 1 diabetes (T1D) and type 2 diabetes (T2D) is increasing and associated with earlier vascular complications and mortality. Dyslipidemia is an important modifiable cardiovascular (CVD) risk factor that is under-recognized and undertreated in youth with T1D and T2D. Given this, we evaluated the prevalence and associations between lipid concentrations and clinical CVD risk factors in youth with T1D compared to T2D at our large ethnically diverse diabetes center. A retrospective chart review was performed, evaluating patients with T1D or T2D seen at least once in clinic from 2015 to 2017, age 10-22 years of age, duration of diabetes at least 6 months on the date of most recent LDL-cholesterol (LDL-C) concentration, and not on statin therapy. We performed independent and multivariable linear regressions of LDL-C and HDL-cholesterol (HDL-C) concentrations. There were 32.7% with T1D (n = 1701) and 47.7% with T2D (n = 298) with LDL-C above recommend goal (> 100 mg/dL/2.6 mmol/L). Furthermore, there were 9% with T1D and 16.4% with T2D with LDL > 130 mg/dL (> 3.4 mmol/L), who likely met criteria for starting statin therapy. Higher LDL-C and/or lower HDL-C were associated with increased age, diabetes duration, higher HbA1...Continue Reading

References

Oct 14, 2004·The Journal of Pediatrics·Jody S KrantzFrancine R Kaufman
Feb 7, 2007·Archives of Pediatrics & Adolescent Medicine·Diana B PetittiUNKNOWN SEARCH for Diabetes in Youth Study Group
Oct 31, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·J A EdgeB Shine
Nov 16, 2011·Pediatrics·UNKNOWN Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, UNKNOWN National Heart, Lung, and Blood Institute
Oct 17, 2013·Diabetes Care·Allison B DartElizabeth A Sellers
May 6, 2014·JAMA : the Journal of the American Medical Association·Dana DabeleaUNKNOWN SEARCH for Diabetes in Youth Study
Aug 30, 2014·Circulation·David M MaahsUNKNOWN American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Dis
Jul 15, 2015·Archives of Endocrinology and Metabolism·Thaís Kataoka HommaLuis Eduardo Procópio Calliari
Jul 21, 2016·JAMA : the Journal of the American Medical Association·Sudhakar V NutiHarlan M Krumholz
Dec 21, 2016·Journal of Pediatric Endocrinology & Metabolism : JPEM·Tuba BulutAyşe Metin
Mar 1, 2017·JAMA : the Journal of the American Medical Association·Dana DabeleaUNKNOWN SEARCH for Diabetes in Youth Research Group
Apr 14, 2017·The New England Journal of Medicine·Aidin RawshaniSoffia Gudbjörnsdottir
Apr 14, 2017·The New England Journal of Medicine·Elizabeth J Mayer-DavisUNKNOWN SEARCH for Diabetes in Youth Study
Apr 23, 2017·Current Diabetes Reports·Amy S Shah, Elaine M Urbina
Mar 3, 2018·Diabetes Care·Maria Jose RedondoUNKNOWN Pediatric Diabetes Consortium
Oct 18, 2018·Current Diabetes Reports·Petter Bjornstad, Robert H Eckel
Dec 14, 2018·Journal of Clinical & Translational Endocrinology·James Heath PelhamAmbika P Ashraf
Dec 19, 2018·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

Epic
Stata

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.